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Abstract 26 
Diets with 50 (SPC50), 65 (SPC65) and 80 % (SPC80) substitution of prime fishmeal (FM) 27 
with soy protein concentrate (SPC) were evaluated against a commercial type control feed 28 
with 35% FM replacement with SPC. Increases in dietary SPC were combined with 29 
appropriate increases in methionine, lysine and threonine supplementation whereas added 30 
phosphorus was constant among treatments. Diets were administered to quadruplicate 31 
groups of 29g juvenile Atlantic salmon exposed to constant light, for 97 days. On Day 63 32 
salmon were subjected to vaccination. Significant weight reductions in SPC65 and SPC80 33 
compared to SPC35 salmon were observed by Day 97. Linear reductions in body cross-34 
sectional ash, Ca:P ratios, Ca, P, Mn and Zn were observed at Days 63 (prior vaccination) 35 
and 97 (34 days post vaccination) while Mg presented a decrease at Day 63, in salmon fed 36 
increasing dietary SPC. Significant reductions in Zn, Ca, P and Ca:P ratios persisted in 37 
SPC65 and SPC80 compared to SPC35 salmon at Day 97. Significant haematocrit reductions 38 
in SPC50, SPC65 and SPC80 salmon, were observed at Days 63, 70 and 97. Enhanced 39 
plasma haemolytic activity, increased total IgM and a rise in thrombocytes were 40 
demonstrated in SPC50 and SPC65 salmon on Day 97, while increased lysozyme activity 41 
was demonstrated for these groups on Days 63, 70 and 97. Leucocyte and lymphocyte counts 42 
revealed enhanced immunostimulation in salmon fed with increasing dietary SPC at Day 97. 43 
High SPC inclusion diets did not compromise the immune responses of salmon while SPC50 44 
diet also supported good growth without compromising elemental concentrations. 45 
1. Introduction 46 
As yet, plant proteins have been the most economically viable alternatives to fish meal (FM) 47 
(Ytrestøyl et al. 2015), representing 37% of salmon diets, which translates to approximately 48 
67% of protein from plants (Ytrestøyl et al. 2015). From this percentage about 38% is 49 
covered by soy protein concentrate (SPC) (Ytrestøyl et al. 2015). However, the ever 50 
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increasing FM prices compared to the stable or decreasing soybean prices could potentially 51 
improve even more the cost efficiency of SPC over FM, making SPC the dominant protein 52 
source in salmon feeds (FAO 2015). SPC is an exceptionally digestible protein source with 53 
high protein content and favourable amino acid profile compared to FM (Dersjant-Li 2002; 54 
Ytrestøyl et al. 2015). It is produced by aqueous alcohol extraction of the soluble 55 
carbohydrates in defatted soy flakes, thus increasing their protein content while reducing the 56 
concentrations of antinutritional factors (ANFs) such as trypsin inhibitors, lectins, saponins 57 
and soy antigens linked to enteritis (Drew et al. 2007). Studies have demonstrated no changes 58 
in the growth of Atlantic salmon fed diets with up to 75% substitution of FM by SPC (Refstie 59 
et al. 1998; Storebakken et al. 1998; 2000; Refstie et al. 2001). Moreover, it has been 60 
reported that diets with even 100% substitution of FM with SPC did not promote any 61 
incidences of soybean induced enteritis in salmonids (Krogdahl et al. 2000; Escaffre et al. 62 
2007).  63 
Additional information is required regarding the effects of increasing dietary plant 64 
protein levels on the growth performance, proximate and elemental compositions of Atlantic 65 
salmon (NRC 2011; Prabhu et al. 2013; 2014). Overall, juvenile salmon appear to be more 66 
sensitive to dietary soy protein inclusion due to the increasing presence of phytic acid in soy 67 
products and the immature state of their digestive tract (Storebakken et al. 1998; 2000; Burr 68 
et al. 2013). Phytic acid bound on the protein fraction of soybeans is the main antinutritional 69 
factor (ANF) found in SPC (Storebakken et al. 1998). Almost three fourths of the P in 70 
soybeans is found in the form of phytic acid,  which not digestible by peptic enzymes, thus 71 
decreasing the availability of P (Francis et al. 2001). Phytic acid inhibits protein hydrolysis 72 
and forms complexes with positively charged cations, proteins and amino acids, reducing 73 
their availability for the fish (Francis et al. 2001; Riche and Garling 2004). Muscle is the 74 
main storage tissue for most nutrients while skeleton consists the principal elemental store 75 
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in fish. Therefore, any changes in nutrient retention could be reflected in the composition of 76 
these tissues. Herein, body cross-sections from the end of the dorsal fin to the start of the 77 
anal fin including muscle, bone, skin and scales (in a similar manner as Norwegian quality 78 
cutlet (NQC) samples are utilised for flesh quality control in market size salmon) were used 79 
for the compositional assessment of both tissues as a whole. Elemental data were compared 80 
with whole body concentrations which are generally used as the golden standard in order to 81 
assess this novel methodological approach (Shearer et al. 1994; Helland et al. 2005; 2006).  82 
In general, there is a lack of information regarding the effects of high dietary levels of 83 
plant proteins on the overall health status of Atlantic salmon. Previously, Krogdahl et al. 84 
(2000) reported increased lysozyme and total IgM levels in the intestinal mucosa of seawater 85 
adapted Atlantic salmon maintained on feeds with 30 % of dietary protein from soy products 86 
(SBM and SPC) compared to FM-fed salmon. Moreover, SPC-fed salmon demonstrated 87 
improved resistance against Aeromonas salmonicida compared to their FM- and soybean 88 
meal (SBM) fed counterparts. While studies on the effects of dietary plant proteins on the 89 
immune status of Atlantic salmon are still scarce, the majority of these were focused on the 90 
effects of these feedstuffs on the innate immune responses of fish that have not been 91 
stimulated immunologically (Thompson et al. 1996). However, determining immune 92 
responses shortly or later post immunisation (via vaccination in the present study) may 93 
highlight dietary modifications that were not evident before (Thompson et al. 1996).  94 
Vaccination in the present study was primarily used in order to provide immunological 95 
stimulation and secondarily to reproduce commercial conditions, as most farmed salmon are 96 
vaccinated for disease prevention during the freshwater stage (Poppe and Koppang 2014). 97 
In fish subjected to vaccination, normal skeletal elemental deposition could be decreased if 98 
these nutrients are required for metabolic and immunomodulatory processes (Lall, 2003; 99 
Kiron 2013). Overall, the negative effects of vaccination on bone development and 100 
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mineralisation depend on fish size at vaccination (Berg et al., 2006; Grini et al., 2011), the 101 
type of the vaccine (Aunsmo et al., 2008) and the culture conditions  (Grini et al., 2011). 102 
With regards to the latter variable, studies have shown that both vaccinated and non-103 
vaccinated salmon exposed to high water temperatures (15-16°C) (used in order to boost 104 
salmon growth) are more prone to changes in their vertebral structure and composition which 105 
translates to a higher prevalence of skeletal pathologies (Ytterborg et al. 2010; Grini et al. 106 
2011). Exposure to continuous light is another common commercial practice, targeting the 107 
prevention of maturation and/or smoltification in juvenile salmon but has also been 108 
associated with an enhancement in salmon growth (Kråkenes 1990; Bromage et al. 2001; 109 
Berrill et al. 2003; Stefansson et al. 2007; 2008). Fjelldal et al. (2005; 2006) reported that 110 
Atlantic salmon post-smolts reared in seawater cages under a continuous light regime, 111 
promoting faster growth, demonstrated lower vertebral mineralisation compared to fish 112 
exposed to natural photoperiod. Therefore, salmon exposure to intensive rearing regimes, 113 
aiming faster growth could negatively affect skeletal mineralisation and development.  114 
The main aim of the study was to assess the growth and health of juvenile Atlantic 115 
salmon fed increasing dietary SPC levels (50, 65 and 80 % of dietary protein from SPC) 116 
against a commercial type control diet with 35% of protein from SPC, under constant light, 117 
a temperature of 13°C and an intensive feeding regime. While the commercial 118 
implementation of salmon diets with higher than 65% of protein from SPC is improbable, 119 
due to the high price of this ingredient compared to other FM alternatives, they were used in 120 
this context in order to amplify responses, which could highlight nutritional deficiencies. 121 
Health was evaluated by assessing immune responses and body cross-sectional composition 122 
prior to (Day 63) and post-vaccination with a commercial vaccine (Day 97/34 days post 123 
vaccination (dpv)).  124 
2. Materials and methods 125 
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2.1. Diets and growth trial 126 
Four experimental diets were prepared. These were formulated so that aqueous-alcohol 127 
extracted SPC (Imcopa, Paraná, Brazil) supplied 35, 50, 65 and 80 % of total dietary protein 128 
(termed SPC35, SPC50, SPC65 and SPC80, respectively) with high quality FM providing 129 
the rest of the dietary protein in all cases. Diet formulations are provided in Table 1. SPC35 130 
served as the control diet. The rationale behind the use of SPC35 as a control treatment was 131 
to mimic commercial salmon dietary compositions with inclusion of plant proteins. In this 132 
case, SPC as a sole plant derived FM substitute was chosen due to its premium nutritional 133 
value. In previous trials, SPC35 treatment had been tested against EWOS commercial feed 134 
formulations and it was found to perform equally well as its commercial counterparts 135 
(personal communication Viv Crampton). The diets were manufactured by EWOS 136 
Innovation, Dirdal, Norway and were formulated so that protein: fat ratios were constant 137 
whereas lysine, methionine and threonine were supplemented to give the same AA: protein 138 
ratios across dietary treatments. The amount of supplemented dicalcium phosphate was 139 
constant among the diets, representing 3% of all experimental dietary formulations, 140 
exceeding Atlantic salmon phosphorus (P) requirement (Lall 2003). 141 
The feeding trial was conducted at EWOS Innovation facilities in Dirdal, Norway. For 142 
the trial, fresh water was supplied to 16 square tanks with rounded corners each containing 143 
approximately 60 litres of water. Water temperature was maintained at 13 ± 1ºC, whilst 144 
photoperiod was constant (24 h of light). The diffused oxygen level of inlet water to the 145 
tanks was constantly 90-100 % saturation. . A total of one thousand nine hundred and twenty 146 
(1920 fish) unvaccinated S0 Atlantic salmon parr (from a commercial SalmoBreed strain 147 
selected for improved growth performance) of an average weight of 29 g (i.e. 120 fish × 148 
tank-1) were randomly allocated to the 16 tanks. Fish were acclimatised to experimental tanks 149 
for 28 days prior to commencing the trial, during which time they were fed a commercial 150 
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EWOS freshwater diet for salmonids (EWOS micro). During the study period quadruplicate 151 
tanks of fish were fed one of the 4 experimental diets. Fish were fed with automatic belt 152 
feeders, continuously every 435 seconds for 20 seconds. Feeding time and period within feed 153 
intervals were the same for the acclimation and trial period. The daily ration depended on 154 
the trial period and fish appetite. A daily ration of 3.5 % of tank biomass was recorded during 155 
the acclimation period, while this proportion was decreased to 2.75, 2.5 and 1.5% of tank 156 
biomass during the first, second and third month of the trial period, respectively. A high 157 
daily feed ration was used to avoid differences in feed intake often associated with satiation 158 
feeding of plant substituted diets (Refstie et al. 1998).  159 
The growth trial was conducted for a total of 97 days, at which time all fish in the tanks 160 
were removed and bulk weighed post anaesthetisation (metacaine, 30 mg × l-1) at Days 36, 161 
63 and 97. At Day 63 and after bulk weighing fish from each tank, blood from 6 individuals 162 
per tank was withdrawn for the evaluation of both haematological and immunological 163 
responses. After blood sampling, body cross-sections between the end of the dorsal fin and 164 
the start of the anal fin, from the same fish were collected for the commencement of 165 
composition analyses in pools of six body cross-sections per tank (4 pools per treatment). 166 
Salmon were then intraperitoneally (i.p.) vaccinated with 100μl of a commercial vaccine 167 
(AquaVac™ Furovac, Intervet UK Ltd., Milton Keynes) against A. salmonicida in order to 168 
simulate commercially applied conditions and most importantly to stimulate immune 169 
responses.  Thereafter, fish were sampled for haematological and immunological evaluation 170 
at Days 70 (7 days post vaccination) and 97 (34 days post vaccination) while body cross-171 
sections were sampled at Day 97 of the trial. 172 
2.2. Sample collection 173 
Blood was withdrawn from the caudal vein of 6 ﬁsh per tank per dietary group on Days 63, 174 
70 and 94 after the start of the study (i.e. pre vaccination, 7 and 34 dpv) using 1 ml syringes 175 
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rinsed with heparin (10 IU × ml-1; Sigma-Aldrich, Dorset, UK), and used to assess a variety 176 
of haematological and immunological parameters in dietary fish. Haematocrit values were 177 
determined for all sampled fish at each sampling point. Total and differential leucocyte 178 
counts were determined from only three fish per tank. Three blood smears were prepared for 179 
each fish for the determination of differential leucocyte counts. The smears were air dried 180 
and subsequently stained with Rapid Romanowsky stain (Raymond A lamb, Eastbourne, 181 
UK) and examined at × 1000 magniﬁcation to determine the percentage of different 182 
leucocyte types and the numbers of these cells per ml of blood according to total leucocyte 183 
numbers. Two pooled blood samples per tank were then obtained (2 pools of 1.2 ml of blood 184 
from three individuals per tank, giving 8 pools of blood per treatment). The blood was 185 
centrifuged at 3000 × g for 20 min at 4ºC and pooled serum then aliquoted into seven 186 
eppendorf tubes (around 40-50 µl per tube) and stored at -80oC until used. 187 
Head kidney samples (approximately 5 mm) from three individuals (from the same 188 
tank), were aseptically removed and pooled into plastic 5-ml bjoux containers containing 5 189 
ml of ice-cold Leibovitz medium (L-15; Sigma-Aldrich) and 40 μl heparin (10 IU × ml -1). 190 
Two pools per tank were used for the determination of the superoxide anion (O-2) production 191 
by head kidney macrophages.  192 
2.3. Head kidney macrophage isolation and macrophage respiratory burst activity  193 
For the isolation of head kidney macrophages (HKMs) the method described by Korkea-aho 194 
et al. (2011) was used. The superoxide anion (O-2) production by head kidney macrophage 195 
suspensions were measured by the conversion of NBT (Sigma-Aldrich) to formazan, 196 
according to the method published by Secombes (1990) with some modifications described 197 
by Korkea-aho et al. (2011).  198 
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2.4. Determination of plasma protein and lysozyme activity 199 
Protein content of plasma was determined by the Pierce BCA (bicinchoninic acid) Protein 200 
Assay kit (Thermo Scientific, IL, USA) based on the conversion of Cu2+ to Cu1+ under 201 
alkaline conditions (Biuret reaction) using bovine serum albumin (BSA) as a standard. 202 
Serum lysozyme activity was based on the lysis of lysozyme sensitive Micrococcus 203 
lysodeikticus as described by Korkea-aho et al. (2011).  204 
2.5. Measurement of natural haemolytic activity (Complement) 205 
Plasma haemolytic activity used was based on a method described by Sirimanapong et al. 206 
(2014) with modifications including a 22°C incubation temperature of the reaction mixture 207 
and the use of four double serial plasma dilutions for the determination of haemolytic activity 208 
starting from an 1:4 dilution. 209 
2.6. Total plasma Immunoglobulin M (IgM) assay 210 
The level of IgM in sera of experimental fish was determined using an indirect enzyme 211 
linked immunosorbent assay (ELISA) described by Sirimanapong et al. (2014), with 212 
modifications including the use of 1:500 and 1:1000 plasma dilutions,  the application of a 213 
monoclonal mouse anti-trout/salmon IgM (F11-Aquatic Diagnostics Ltd, Stirling, Scotland) 214 
diluted 1:66 in antibody buffer (1% BSA in LSWB) for 1 h at 22°C and lastly the use of goat 215 
anti-mouse immunoglobulin-G labelled with horseradish peroxidase (HRP) (Sigma-Aldrich) 216 
diluted 1: 4000 in conjugate buffer (1% BSA in LSWB) for 60 min at 21°C.  217 
2.7. Determination of antibody titres against A. salmonicida 218 
An ELISA was used to measure the specific antibody response of Atlantic salmon to the A. 219 
salmonicida vaccine using a modification of the method outlined by Adams et al. (1995). 220 
2.8. Antiprotease Activity 221 
The method used was designed to detect anti-protease activity in trout plasma, and was 222 
based on the method described by Ellis (1990), modified for use in microtitre plates. 223 
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2.9. Calculations 224 
Estimated feed conversion ratios (FCRs) in the current trial were based on the feed amount 225 
given to the fish and do not represent the actual FCR; therefore they were not included in 226 
the current report or statistical analyses. For simplicity, growth performance was evaluated 227 
by monitoring the mean salmon weight from each tank and estimating the weight gain of the 228 
experimental salmon groups: 229 
Weight gain (WG): 230 
WG =
𝐵𝑖𝑜𝑚𝑎𝑠𝑠 𝑓𝑖𝑛𝑎𝑙 (𝑔)−𝐵𝑖𝑜𝑚𝑎𝑠𝑠 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 (𝑔)
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑖𝑠ℎ
 231 
Specific Growth Rate (SGR): 232 
𝑆𝐺𝑅 = (
𝑙𝑛𝑊1 − 𝑙𝑛𝑊0
𝑡
) × 100 233 
Thermal Growth Rate (TGC):   234 
𝑇𝐺𝐶 = (
√𝑊1
3
− √𝑊0
3
(𝑡 × 𝑇)
) × 100 235 
where W1 is the group’s average weight at each timepoint of the feeding trial (g) and W0 is 236 
the group’s average initial weight (g). T is the water temperature (°C) and t is the duration 237 
of the experiment (number of days). 238 
2.10. Proximate composition analysis 239 
Cross-section samples obtained as described at the end of the Section 2.1 were stored frozen 240 
and then thawed prior to analysis. Feeds were homogenised prior to the analysis. Dry matter 241 
and moisture were determined according to standard methods (AOAC 1990) by oven drying 242 
of both homogenised feeds and pooled body cross-sections, for 16 h at constant weight. After 243 
drying the pooled cross-sections were homogenised and used for ash, crude protein, crude 244 
lipid and elemental determination. Pulverised body cross-section and feed samples were 245 
ashed in a muffle furnace at 550°C according to (AOAC 1990). Crude protein was estimated 246 
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by the Kjeldahl method using the Tecator Kjeltec System (AOAC 1990) and crude fat was 247 
determined using Soxhlet extraction with chloroform: methanol  (2:1 v/v) (Christie 2003). 248 
Minerals and phosphorus from homogenised feed and dried body cross-section pools were 249 
determined using inductively coupled plasma mass spectroscopy, ICP-MS with collision cell 250 
technology (CCT) (Thermo X Series 2). One hundred milligrams of pooled body cross-251 
section homogenates were added to Teflon digestion tubes with 5 ml of 69 % nitric acid. The 252 
tubes were then put into a microwave digester (Mars Fish digester) for the initiation of the 253 
digestion process (Step 1: 21-190°C for 10 min at 800 W; Step 2: 190°C for 20 min at 800 254 
W; Step 3: 190-21°C for 30 min cooling period). Samples from digestion tubes were then 255 
poured into 10 ml volumetric flasks and made up to 10 ml with the addition of distilled water. 256 
Four hundred µl of the diluted digested material were poured into another plastic 10 ml 257 
sample tube and made up to a final volume of 10 ml with distilled water prior to measuring 258 
the elemental concentration within pooled dried carcass and bone homogenates using ICP-259 
MS. Mineral concentration was calculated as µg × g-1 using the following equation: 260 
𝐸𝑙𝑒𝑚𝑒𝑛𝑡𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
µ𝑔
𝑔
) =
𝑆𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝑙)
1000
×
𝑅𝑒𝑠𝑢𝑙𝑡 𝑓𝑟𝑜𝑚 𝐼𝐶𝑃
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
 261 
Dietary phytic acid-bound P levels were estimated using a Megazyme Phytate/Total 262 
Phosphorus Assay kit (Megazyme, Ireland). After estimating the % of P bound to phytic acid 263 
from the total amount of P in the diet using the kit, the concentration of P bound to phytic 264 
acid and the amount of phytic acid were extrapolated from the concentration of P estimated 265 
via ICP/MS.  266 
2.11. Statistics 267 
Growth trajectories based on the mean weight estimates at Day 36/prior vaccination, Day 268 
63/prior vaccination and Day 97/ 34 days post vaccination were modelled as repeated 269 
measures (Crampton et al. 2010; Espe et al. 2012). Growth performance indices (mean daily 270 
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weight gain, SGR and TGC) were also assessed in a similar manner. Moreover, a hierarchical 271 
(multilevel) statistical model was used for body cross-sections composition, haematological 272 
and composition data from each tank, since multiple observations from a single tank were 273 
available (several pools) (Espe et al. 2012; Nanton et al. 2012; Hartviksen et al. 2014). The 274 
statistical analysis was carried out with the help of the R language (R Core Development 275 
Team 2014) and its lme4 package (Bates et al. 2014). The statistical approach applied was 276 
model-based. This means that to find if any specific effect was statistically significant data 277 
were fitted in three different models with increasing complexity where tank was included as 278 
a random effect, sampling time as a categorical variable and the percentage of protein from 279 
SPC as a continuous factor possibly having non-linear effects: 280 
1. a model with only sampling time (Tank considered as a random effect). 281 
2. a model with sampling time and % protein from SPC with their interaction (Tank 282 
considered as a random effect). 283 
3. a model as above but with an additional quadratic effect of % protein from SPC with 284 
interactions to reveal any non-linearity in the response (Tank considered as a random 285 
effect). 286 
The three models were nested and compared with a likelihood ratio test (LRT) that evaluated 287 
if the improvement in the likelihood required a more complex model or whether the simpler 288 
model could be applied. Models demonstrating possibilities (P values) < 0.05 were selected 289 
for the description of data. The simplest possible model was adopted according to Occam's 290 
razor principle. The adopted model was demonstrated by plotting the expected mean 291 
response with 95% confidence intervals. For a categorical effect these were represented as 292 
points with error bars and for a continuous effect as a curve with shaded confidence region. 293 
The expected mean and 95% confidence intervals were solved by a posterior simulation from 294 
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the adopted statistical model (n=1500 random draws were used throughout this study) 295 
(Gelman and Hill 2007). 296 
3. Results 297 
3.1. Growth performance 298 
The mortalities among the four experimental groups of Atlantic salmon were negligible 299 
(<1%) for all groups (Table 2). Fig. 1 demonstrates the weight development of the four 300 
dietary groups of Atlantic salmon. The models with the linear effect of the dietary percentage 301 
of protein from SPC were favoured using the LRTs (likelihood ratio tests) for both expected 302 
mean weight of salmon and expected mean daily weight gain (WG) (Statistical models are 303 
presented in Fig. 2A and 2B). The expected mean values of the aforementioned growth 304 
parameters with their estimated 95% confidence intervals (C.I.) are presented with different 305 
colour for each timepoint or period respectively. More specifically the black line (expected 306 
mean values) and its corresponding shaded region (estimated 95 % C.I.) represents the 307 
expected mean weight values for Day 36 and the expected mean WG for the pre vaccination 308 
period from Day 0 to Day 36. The values in red represent the mean weight estimates for Day 309 
63 and the expected mean daily WGs for the pre-vaccination period from Day 36 to Day 63, 310 
while values in blue demonstrate the corresponding values for Day 97 and the post 311 
vaccination period, from Day 63 (day of vaccination) to Day 97 (34dpv). Overall, increasing 312 
SPC levels resulted in lower mean weight and daily WG in Atlantic salmon juveniles at all 313 
timepoints of the study. Approximate reductions of 12 and 10% in expected mean weight 314 
were observed in SPC80 compared to SPC35 salmon at Day 36 and 63 of the feeding trial 315 
respectively, while an 8% reduction in weight was demonstrated at Day 97 (34dpv) between 316 
the two dietary groups (Fig. 2A). Moreover, SPC65 and SPC80 salmon exhibited 317 
significantly lower mean weights compared to the SPC35 group at all timepoints. In a similar 318 
manner, the reduction in daily WG observed in the high SPC inclusion dietary groups was 319 
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improved at post-vaccination compared to the SPC35 group. This could be observed by the 320 
slope of the WG curve for the post-vaccination period when 8% reduction in WG for SPC80 321 
compared to SPC35 salmon was recorded. This slope was much shallower compared to the 322 
slopes obtained for the pre-vaccination periods, when 17 and 10% reduction in WG in SPC80 323 
compared to SPC35 salmon  was observed (Fig. 2B). Overall, SPC65 and SPC80 salmon 324 
demonstrated significantly lower mean daily WG compared to the SPC35 group, for the first 325 
(Day 0 –Day 63) and second (Day 63 – Day 97) period of the feeding trial while no 326 
differences were noted for the last bit of the study, further supporting the improved 327 
performance of fish receiving higher SPC levels compared to the SPC35 group. SGR and 328 
TGC values for the experimental groups did not present significant differences among the 329 
four dietary groups and were only affected by the study period and the developmental stage 330 
of the fish. Overall, Atlantic salmon experienced the highest SGR and TGC values during 331 
the first part of the study, while the lowest values were demonstrated at the last part of the 332 
study and after the vaccination of the fish, while intermediate SGRs and TGCs were 333 
exhibited for the second period of the study. 334 
3.2. Proximate and elemental composition of pooled body cross-sections 335 
No differences due to the inclusion of SPC in the feeds were demonstrated among dietary 336 
groups of salmon in terms of lipid, protein and moisture concentrations; whereas a linear 337 
reduction in body cross-section ash levels both prior to vaccination (Day 63) and at 34 dpv 338 
(Day 97) was demonstrated in salmon fed on high dietary levels of SPC (Model is plotted in 339 
Fig. 3A). Overall, moisture, lipid and protein concentrations were only affected by time. 340 
Expected ash values in salmon juveniles were affected linearly by the increased inclusion of 341 
SPC in the diets with the SPC80 group demonstrating a 13% decrease in credible ash content 342 
compared to SPC35 salmon at Day 63. Lower ash levels were demonstrated at Day 97 (34 343 
dpv) for all dietary groups. However, the groups receiving lower levels of dietary protein 344 
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from SPC were the ones demonstrating the highest reduction in body cross-section ash 345 
levels. A 5% reduction in expected ash concentration was demonstrated in SPC80 compared 346 
to the SPC35 salmon at Day 97.   347 
Expected calcium to phosphorus (Ca:P) ratio, calcium (Ca), phosphorus (P), 348 
manganese (Mn) and zinc (Zn) levels in pooled body cross-section samples were affected  349 
in a linear fashion by increasing levels of dietary SPC, since the model with linear description 350 
of the data was found to describe the data in a better manner compared to the other two 351 
models (Models selected are presented in Fig. 3B, 3C, 3D, 4B and 4C). Therefore the dietary 352 
groups receiving feeds with higher levels of SPC inclusion exhibited lower amounts of the 353 
abovementioned elements. On the other hand, the model showing a quadratic effect of the 354 
percentage of dietary SPC, improved the fit over the linear model for body cross-section 355 
expected Mg levels (Model selected is plotted in Fig. 4A). Overall, at Day 63, SPC35 salmon 356 
demonstrated significantly higher Ca: P ratio, Ca, P and Mg concentrations than the SPC50, 357 
SPC65 and SPC80 groups and higher amounts of Zn and Mn in comparison to the SPC65 358 
and SPC80 groups.  359 
In general, lower body cross-sectional elemental amounts were demonstrated for all 360 
dietary groups at Day 97 (34 dpv) compared to Day 63 (prior to vaccination). At this 361 
timepoint significantly lower Ca: P ratio, Ca, P and Zn concentrations were recorded for 362 
SPC65 and SPC80 salmon compared to the SPC35 group. Despite the observed reduction in 363 
body cross-section elemental concentrations at Day 97 compared to Day 63, an overall 364 
improvement in expected Ca:P ratio, Ca, P, Mg and Mn was demonstrated from the modelled 365 
based statistical analysis in vaccinated salmon receiving increased dietary SPC. This was 366 
apparent from the slope  connecting the expected mean values for the dietary groups at this 367 
timepoint (blue lines in Fig. 3B, 3C, 3D, 4A and 4C) which was much shallower compared 368 
to Day 63 and the fact that SPC35 salmon was the group demonstrating the greatest reduction 369 
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for all elements except Zn compared to the other groups. Expected Zn was the only mineral 370 
with no marked improvement in the body cross-sections of Atlantic salmon fed increasing 371 
dietary SPC-inclusions, at Day 97 (34dpv).  372 
3.3. Haematological and Immunological responses 373 
Haematocrit declined with increasing dietary proportions of SPC at all time-points 374 
(Modelled response is presented in Fig.5A). Significant differences were demonstrated 375 
between SPC80 compared to SPC35 salmon prior vaccination/PBS injection (since the 376 
expected confidence intervals given with the shaded regions for each treatment are 377 
overlapping with the expected mean values of the four groups). Overall lower haematocrits 378 
were obtained at 7 dpv. The decrease in haematocrit values with increasing SPC inclusion 379 
was much more noticeable at 7 dpv compared to the other sampling dates. At 7dpv, 380 
haematocrit decreased significantly in the SPC50, SPC65 and SPC80 groups compared to 381 
SPC35 salmon. At 34dpv despite the slight increment in haematocrit values exhibited in the 382 
former groups, salmon receiving diets with higher than 35% of protein from SPC 383 
demonstrated significantly lower haematocrits compared to the SPC35 group. Higher 384 
haematocrit levels were recorded for all groups at 34 dpv in comparison to the previous 385 
timepoints. 386 
Similar trends were obtained for leucocyte numbers during the two first time-points 387 
(pre vac and 7 dpv) with decreasing numbers observed upon increased dietary SPC inclusion. 388 
Significant differences were revealed for the SPC65 and SPC80 groups compared to SPC35 389 
salmon at both timepoints, while increased leucocyte counts were demonstrated for all 390 
dietary groups at 7dpv compared to pre vaccination levels. However, at 34 dpv leucocyte 391 
concentrations followed the opposite pattern, demonstrating increasing numbers in salmon 392 
fed diets with increasing dietary SPC inclusion (Modelled response is presented in Fig. 5B). 393 
No significant differences in total leucocyte levels were recorded among the three dietary 394 
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groups of salmon at this timepoint. Regarding the expected differential leucocyte numbers, 395 
lymphocytes and thrombocytes were the only types of leucocytes affected by increasing SPC 396 
inclusion. Lymphocytes followed similar trends to that of total leucocytes. Prior to 397 
vaccination and at 7 dpv, lymphocyte numbers exhibited a linear reduction in salmon fed 398 
diets with increasing levels of SP. Significantly lower lymphocyte numbers were detected in 399 
SPC50, SPC65 and SPC80 salmon compared to SPC35 salmon before the vaccination of the 400 
fish. However, at 7 dpv lymphocyte numbers exhibited a slight increase in salmon fed on 401 
diets with higher than 35% of total protein from SPC, whereas SPC35 salmon lymphocytes 402 
presented a slight reduction. At this point significantly lower lymphocyte counts were 403 
demonstrated in SPC65 and SPC80 salmon in contrast to the SPC35 group of fish. At 34 dpv 404 
a linear increase in lymphocytes was observed in salmon fed with higher dietary amounts of 405 
SPC (Modelled response is presented in Fig. 5C). Nonetheless, no differences on lymphocyte 406 
levels were recorded among the three dietary groups at 34dpv. On the other hand, 407 
thrombocytes were affected curvilinearly in salmon fed increasing amounts of SPC with 408 
SPC50 and SPC65 salmon demonstrating the highest levels of thrombocytes and the SPC35 409 
group having slightly higher thrombocyte numbers than SPC80 salmon, at all time- points 410 
(Modelled response is presented in Fig. 5D). However, no significant differences were 411 
revealed prior to and 7 dpv. Overall, thrombocytes increased upon vaccination with levels 412 
peaking at 34 dpv. At this point significantly higher thrombocyte levels were demonstrated 413 
for the SPC50 and SPC65 groups compared to SPC35 salmon. Increasing dietary SPC 414 
inclusion had no significant effect on circulating granulocyte and monocyte levels of 415 
juvenile salmon. Neutrophilic granulocytes increased after vaccination peaking up at 7 dpv, 416 
while at 34 dpv the levels of these leucocytes decreased. Contrary to the results above, 417 
monocytes demonstrated a gradual increase post-vaccination, showing the highest levels 34 418 
dpv. 419 
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Statistical models revealed no effect of increasing dietary SPC inclusion on the 420 
respiratory burst activity of both PMA-stimulated and non-stimulated HKMs. Head kidney 421 
macrophages in general demonstrated increased respiratory burst activity a week after 422 
vaccination and a subsequent reduction to pre-vaccination levels, at 34dpv.  423 
Increasing dietary SPC inclusion in the diets of Atlantic salmon parr had no significant 424 
effect on their plasma protein levels and plasma anti-protease activity. Plasma protein 425 
concentrations demonstrated a sharp reduction at 7 dpv compared to pre-vaccination levels. 426 
At 34 dpv plasma protein presented an increase compared to protein levels at 7 dpv. 427 
Nonetheless, protein levels at this timepoint were found to be lower than pre-vaccination 428 
values. Plasma anti-protease, activity on the other hand, presented a gradual decrease at the 429 
post-vaccination period compared to pre-vaccination levels, with the lowest activity 430 
obtained at 34dpv. Plasma specific antibody titres against A. salmonicida were only 431 
measured at 34 dpv, so there was no time effect to model. Thus, the plausible statistical 432 
models consisted of only the SPC inclusion effects. The likelihood comparison demonstrated 433 
no effect of dietary SPC inclusion, however. 434 
Increasing SPC levels in the diets had a curvilinear effect on plasma lysozyme activity, 435 
total IgM levels and haemolytic activity (Modelled responses are presented in Fig. 6A, 6B 436 
and 6C). At prior to vaccination, expected lysozyme activity, appeared to be higher in salmon 437 
receiving the SPC50 and SPC65 dietary treatments compared to the SPC35 and SPC80 438 
salmon. Significant differences were also demonstrated between the former two groups and 439 
SPC35 salmon. At 7dpv a similar trend was observed, however, the levels of lysozyme 440 
activity were markedly higher than prior to vaccination. At this point significantly higher 441 
lysozyme activity was demonstrated for the SPC65 group of fish in contrast to SPC35 442 
salmon. The pattern of lysozyme activity with respect to the level of dietary SPC inclusion 443 
was the same at 34 dpv, as seen with the previous time points, however the activity was 444 
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lower than prior to vaccination. Moreover, significantly higher activity was demonstrated in 445 
SPC50 and SPC65 salmon compared to the SPC35 group (Modelled response is shown in 446 
Fig. 6A). Expected plasma IgM levels prior to vaccination demonstrated no differences 447 
among the four dietary groups of salmon. At both post vaccination points (7dpv, 34dpv), 448 
total plasma IgM concentrations were found to be significantly higher for SPC50 and SPC65 449 
salmon compared to SPC35 salmon while similar levels were demonstrated for SPC35 and 450 
SPC80 salmon (Modelled response is illustrated in Fig.6B). Expected haemolytic activity 451 
demonstrated minor differences among the four experimental dietary groups of salmon prior 452 
to and at 7 dpv. However, at 34 dpv plasma haemolytic activity presented a salient increase 453 
for fish from all the dietary treatments with fish fed on medium levels of SPC inclusions 454 
possessing the highest values. Significant differences were denoted for the SPC50, SPC65 455 
and SPC80 groups in comparison to SPC35 salmon at 34dpv (Modelled response is shown 456 
in Fig.6C). 457 
4. Discussion 458 
4.1. Growth  459 
Phytic acid in soybean products has been proven to reduce nutrient digestibility, inhibit the 460 
activity of gastrointestinal enzymes and compromise dietary intake, feed efficiency and fish 461 
growth (Destandli et al., 2006; Kumar et al. 2012). Compositional analyses of the tested 462 
treatments demonstrated an increase in the phytic acid concentrations upon increased dietary 463 
inclusion of SPC which could explain the reductions on juvenile salmon growth performance 464 
(Destandli et al. 2006). The reductions in salmon mean weight and daily WG were much 465 
more evident during the first (Day 0 - Day 36) and second period (Day 36 – Day 63), prior 466 
to salmon vaccination, while improved growth was observed at post vaccination, during the 467 
last part of the study, indicating a slow but steady adaptation of juvenile salmon to diets with 468 
increasing levels of SPC. Burr et al. (2012) noted that the growth performance of Atlantic 469 
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salmon parr fed diets in which protein was supplied from alternative protein blends improved 470 
with the age of the fish, with late stage parr presenting improved growth. In the present study, 471 
despite the overall reduction in mean weight, an improvement in WG was witnessed for high 472 
SPC inclusion dietary salmon during the post-vaccination period. This was an indication that 473 
larger size Atlantic salmon can utilise the nutrients of these diets more efficiently either due 474 
to having a more developed digestive tract or due to the fact that they require a longer 475 
adaptation time to accept these diets, which is in accordance with the findings of Burr et al. 476 
(2012). Despite the observed significant reduction in the growth performance of the SPC80 477 
compared to the SPC35 group, numerically this decrease was not substantial. Overall, weight 478 
reduction in SPC80 compared to SPC35 salmon was only 8% upon completion of the study 479 
and was much lower than weight differences observed in salmon fed diets entirely based on 480 
different FM varieties (Anderson et al. 1997). 481 
The lower WG values observed at post vaccination (Day 63-Day 97) compared to the 482 
pre vaccination period from Day 36 to Day 63 (Fig. 2B), despite the longer duration and the 483 
larger size of the fish at the former phase, could be attributed to the stressful nature of the 484 
vaccination process reducing fish appetite and growth modulating hormones (Pickering 485 
1993; Wendelaar Bonga 1997). Moreover, decreased energy expenditure for growth due to 486 
immune induction is expected at post vaccination (Van Muiswinkel and Wiegertjes 1997;  487 
Melingen and Wergeland 2000).  488 
4.2. Body cross-sectional composition  489 
To overcome any differences attributed to dietary P limitations in SPC,  30 g × kg-1 of 490 
dicalcium phosphate was added in all experimental diets, exceeding the minimum reported 491 
dietary P requirements for Atlantic salmon which was previously estimated at around 10-11 492 
g × kg-1 (Åsgard and Shearer 1997; NRC 2011; Prabhu et al. 2013). Analysis of the diets 493 
also confirmed that available P levels (total P - P bound to phytic acid) were found to be 494 
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close to the reported requirement range, from 13.4 - 10.6 g × kg-1, decreasing progressively 495 
upon increased SPC inclusion (Storebakken et al. 1998).  496 
Body cross-sectional proximate and elemental composition analysis revealed a linear 497 
reduction in expected ash, Ca:P ratio, Ca, P, Mn, and Zn content and an overall reduction of 498 
Mg in juvenile salmon fed on increasing dietary SPC levels prior to (Day 63) and 34 dpv 499 
(Day 97). Estimated body cross-sectional P, Ca, Mg and Mn concentrations at Day 63 were 500 
similar to the whole body contents reported by Helland et al. (2005; 2006) for healthy 501 
juvenile Atlantic salmon of comparable size. Zinc levels at Day 63 were also found within 502 
the range reported by Helland et al. (2006), however these values were closer to the lower 503 
end of this distribution, suggesting either limitations in the use of body cross-sections for the 504 
estimation of this mineral or the onset of Zn deficiency in salmon. Similarly, Ca:P ratio 505 
which usually lies close to 1:1 in whole body samples was found to range from 0.8-0.9 506 
suggesting reduced skeletal calcification at Day 63 (Shearer et al. 1994; Helland et al. 2006). 507 
At Day 97 (34 dpv), elemental concentrations and Ca:P ratio were lower compared to the 508 
first timepoint, and the whole body values previously described by Helland et al. (2005; 509 
2006), which could be an indication of salmon with subclinical deficiencies for all the above 510 
elements.  Nonetheless, no apparent signs of elemental deficiencies were recorded for any 511 
of the dietary groups of salmon such as growth reductions, increased mortalities, lens 512 
cataracts, fin and skin erosions or morphological anomalies (Lall 2003). 513 
Similarly to our findings, Storebakken et al. (1998) reported decreased levels of whole 514 
body ash, P, Ca Mg, Zn and Ca:P ratio in salmon fed diets with 75% of dietary protein from 515 
SPC and 30 g × kg-1 of supplementary dicalcium phosphate  for 84 days compared to FM-516 
fed salmon. Increased presence of phytic acid in diets with higher SPC content, negatively 517 
affects P availability (Storebakken et al. 1998; Lall 2003), as shown by the chemical 518 
compositions of the four diets used in the present study. Inadequate dietary uptake of 519 
22 
 
phosphorus might lead to the inability of the fish to retain several minerals including Ca and 520 
Mg (Åsgard and Shearer 1997; Storebakken et al. 1998). In addition to that, the chelating 521 
effects of this substance on positively charged ions such as Ca, Mg, Mn and Zn and the 522 
formation of insoluble salts within the gut are the main reasons for the observed reduction 523 
of these minerals in whole body samples (Francis et al. 2000; Lall 2003). Therefore, it is 524 
suggested that increased dietary SPC inclusion in salmon diets should be combined with an 525 
appropriate increment in dietary P supplementation. An alternative solution, of great 526 
potential, would be the use of graded levels of phytases which are enzymes that can break 527 
down phytic acid and their salts, increasing the availability of P and several other essential 528 
macro- and micro-nutrients from plant feedstuffs such as SPC (Storebakken et al. 1998; 529 
Cheng and Hardy 2003; Carter and Sajjadi 2011). Phytase can be applied prior pelleting or 530 
onto pellets (Denstadli et al. 2007; Wang et al. 2008). However, the high processing costs, 531 
the existent inconsistencies regarding the optimum doses of phytase in salmon plant based 532 
feeds for the replacement of inorganic P, the inactivation of the enzyme at high temperatures 533 
required for pelleting (>80°C) or certain storage temperatures and the narrow optimum pH 534 
range for its activation are the main limiting factors for the current use of phytase in 535 
commercial salmon feeds (Carter and Sajjadi 2011; Kumar et al. 2012).  536 
The present study shows that diets with higher than 50% of dietary protein from SPC 537 
require higher than 30 g × kg-1 of dicalcium phosphate supplementation in order to promote 538 
both good growth and sufficient bone mineralisation. Studies on salmonids have shown that 539 
diets supplemented with phosphates of a low Ca: P ratio (≤ 1) are more digestible, improving 540 
the availability of P to fish (Aliphos 2012). Therefore, monocalcium or monoammonium 541 
phosphates might be more appropriate inorganic P sources compared to dicalcium phosphate 542 
in high plant protein inclusion diets (Aliphos 2012). Additional fortification of such diets 543 
with other nutrients (vitamins or minerals) should not be excluded (Prabhu et al. 2013; 2014; 544 
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Torstensen 2014), with Zn being a predominant candidate mineral to consider for increased 545 
supplementation upon increased addition of plant proteins in salmon feeds as shown by the 546 
present data (Helland et al. 2006; Prabhu et al. 2014). In an era of dynamic changes in the 547 
protein sources used in aqua-feeds, Atlantic salmon elemental requirements (NRC 2011), 548 
should be re-assessed so that the requirements of salmon grown on diets with higher plant 549 
protein inclusions are met (Prabhu et al. 2013; 2014). Hence, the assessment of elemental 550 
availability from commercially applied alternative dietary protein sources and identification 551 
of Atlantic salmon elemental requirements according to their growth rate and life stage, are 552 
of uttermost importance in order to proportionately balance the inclusion of these nutrients 553 
in their dietary premixes (Torstensen et al. 2008; Prabhu et al. 2013; 2014).  554 
The reduction in body cross-sectional ash, Ca: P ratio, Ca, P, Mg, Mn, and Zn levels 555 
detected at Day 97 (34 dpv) of the study compared to Day 63 (prior vaccination) seems to 556 
have a multifactorial cause. Storebakken et al. (1998) stated that reductions in body 557 
elemental concentrations at different production stages could be attributed to differences in 558 
fish size. Vaccination with injectable oil-based vaccines can also exert a negative effect on 559 
the mineral status of salmon (Berg et al. 2006; Grini et al. 2011; Berg et al. 2012). However, 560 
the negative impacts of injection-vaccination on salmon skeletal mineral levels are often 561 
combined with intensive culture conditions inducing faster growth (Grini et al. 2011; Fjelldal 562 
et al. 2012). Herein, the primary reason for the observed elemental reductions seems to be 563 
the enhanced growth performance of salmon, promoted by the application of continuous 564 
light (combined with favourable temperature of ~13°C for salmon growth) and the intensive 565 
feeding regime which represent the commercial reality (Kråkenes et al. 1991; Fjelldal et al. 566 
2005; 2006; Stefansson et al. 2008). These conditions have led to the achievement of almost 567 
double daily WG and ~1.6 greater weight in juvenile salmon compared to the study 568 
performed by Helland et al. (2006), despite the fact that fish have been subjected to 569 
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vaccination during the last part of the trial. Fjelldal et al. (2006) reported that fast growing 570 
Atlantic salmon post-smolts after 6 months under continuous light demonstrated lower 571 
mineral content and mechanical strength in vertebral bones than slower growing salmon 572 
under natural light. Rungruangsak-Torrissen et al. (2009) added that increased growth in 573 
salmon by exposure to continuous light could be associated with reduced vertebral 574 
mineralisation and strength. Moreover, Hernandez et al. (2000) noted that during periods of 575 
fast growth, the actual time required for the bone matrix to be produced and mineralised 576 
could be decreased to a critical level, resulting to under-mineralised bony tissues. This was 577 
one of the proposed explanations for the higher incidence of vertebral deformities in fast 578 
growing under-yearling Atlantic salmon smolts compared to slower growing yearling smolts 579 
(Fjelldal et al. 2006). In addition, Stefansson et al. (2007; 2008) noted that juvenile Atlantic 580 
salmon reared under constant light (as a means of blocking salmon maturation and 581 
smoltification) could develop into “pseudo-smolts” exhibiting all the external changes, 582 
characterising smoltifying salmon but not the physiological changes required for seawater 583 
adaptation. Therefore, disturbances in ion and osmo-regulation of salmon due to “pseudo-584 
smoltification” could have led to reduced elemental levels at Day 97. 585 
Despite the observed decline in elemental levels at Day 97 compared to Day 63 in all 586 
dietary groups, salmon fed on higher dietary SPC levels demonstrated subsidiary decrements 587 
in body cross-sectional ash and elemental concentrations (Zn excluded) compared to Day 63 588 
(Fig. 3, 4A & 4C). On the contrary, the decrements in body cross-sectional elemental levels 589 
were much more evident in the groups fed lower dietary SPC levels, with SPC35 salmon 590 
demonstrating the greatest reductions regarding ash and mineral concentrations by 591 
comparison to Day 63. The improvement in elemental retention observed in salmon fed diets 592 
with increasing dietary amounts of SPC could primarily be attributed to the overall delayed 593 
growth performance of these groups compared to SPC35 salmon. Fjelldal et al. (2010) 594 
25 
 
reported that in the long term, high plant protein inclusion feeds could have a positive impact 595 
on the skeletal health of Atlantic salmon post-smolts by delaying salmon growth. Possible 596 
extension of the study could have eliminated the elemental differences among the four 597 
dietary groups. In addition to the overall delayed growth, better assimilation of high SPC 598 
inclusion feeds (either through improved feed intake and/or digestibility) is suggested by the 599 
improvement in the growth performance (daily WG) of these groups, during the last period 600 
of the study (post-vaccination period from Day 63 to Day 97) (Fig. 2B). Earlier studies 601 
suggest that Atlantic salmon requires long adaptation periods in order to accept and start 602 
utilising efficiently high plant protein diets, after which they might be able to compensate 603 
growth and nutrient uptake (Torstensen et al. 2008; Burr et al. 2011). Moreover, according 604 
to Prabhu et al. (2013; 2014), the elemental requirement for WG in farmed fish differs from 605 
the requirement for proper skeletal mineralisation and these depend on both the growth rate 606 
and the life stage of the fish. Herein, it was evident that during the last period of the study, 607 
high SPC inclusion diets performed better by comparison to the first two periods and 608 
matched more closely the elemental requirements of the fish they were allocated to, for both 609 
growth and skeletal mineralisation compared to their SPC35 counterpart.  610 
4.3. Haematological and Immune responses 611 
For Atlantic salmon, haematocrit values, which represent the oxygen carrying capacity of 612 
blood, normally range from 35 to 60 % (Hardie et al. 1990; Thompson et al. 1996). 613 
Haematocrit levels were found to be within this range in the present study. Decreasing 614 
haematocrit however, was observed in salmon fed diets with increasing dietary SPC protein. 615 
Hemre et al. (2005) reported decreased erythrocyte size in Atlantic salmon fed diets with 616 
increased protein levels from soybeans, which could explain the lower haematocrit in these 617 
groups.  618 
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Increased circulatory leucocytes mainly attributed to simultaneous increments in both 619 
lymphocyte and thrombocyte numbers reveal immune and haemostatic stimulation at 34 dpv 620 
for all dietary groups (Nikoskelainen et al. 2007; Silva et al. 2009). Overall, the state of 621 
leucocyto- and lymphocyto-penia in salmon fed increasing amounts of SPC prior to 622 
vaccination and 7 dpv could be accredited to poorer nutrition of these fish caused by the 623 
increasing presence of phytic acid (Fletcher 2011). Furthermore it is possible that salmon 624 
fed on diets with moderate and high SPC inclusion, due reduced nutrient uptake, could have 625 
exhibited suppression of various pathways including the ones involved in systemic immunity 626 
and possibly haematology, utilizing most of the dietary energy for growth (Tacchi et al., 627 
2012). A slow but steady reversal of this trend however, seems to occur upon vaccination 628 
(at 34 dpv), with salmon fed increasing dietary SPC inclusion investing more energy on 629 
immunostimulation which is revealed by the linear increase in lymphocyte numbers 630 
(Nikoskelainen et al. 2007). Moreover, increased haemostatic stimulation was exhibited in 631 
SPC50 and SPC65 compared to the SPC35 and SPC80 salmon, as suggested by the higher 632 
thrombocyte levels (haemostasis regulating cells) recorded for these groups at 34 dpv (Silva 633 
et al. 2009). The increase in granulocyte and monocyte levels at post-vaccination were in 634 
accordance to earlier reports by Chin and Woo (2005) and  Nikoskelainen et al. (2007), 635 
demonstrating significant increases in the circulating numbers of these cells in salmonids 636 
vaccinated against different pathogens. However, no differences were exhibited among the 637 
dietary groups, suggesting that increasing dietary SPC does not compromise the production 638 
of these cells. 639 
Respiratory burst of both PMA-stimulated and naive HKMs did not appear to be 640 
affected by dietary SPC inclusion. In accordance Bransden et al. (2001), reported unaffected 641 
neutrophil oxygen radical production in Atlantic salmon fed on dehulled lupin meal at 40% 642 
inclusion. Contrarily Burrells et al. (1999) demonstrated reduction of HKM respiratory burst 643 
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activity in rainbow trout (Oncorhynchus mykiss) fed diets with 80 % substitution of FM with 644 
dehulled solvent extracted SBM. The decreased post vaccination plasma protein levels 645 
observed in the dietary groups could be attributed to stress-induced reduction of fish appetite 646 
(Melingen and Wergeland 2000). Nevertheless, no differences in plasma protein 647 
concentrations were exhibited among the dietary groups of salmon. Reduced anti-protease 648 
activity have been reported in salmon after vaccination or infection via intra-peritoneal 649 
injection (Secombes and Olivier 1997), which is in agreement with the present findings. 650 
Similarly to plasma protein levels, no differences in anti-protease activity were exhibited 651 
among the groups. Unaffected anti-protease activity in Atlantic salmon fed on diets with 652 
40% substitution of FM with dehulled lupin meal has been reported by Brandsen et al. 653 
(2001). Unaltered lysozyme activity has been previously demonstrated in rainbow trout fed 654 
with up to 100 % of dietary protein from plant derived feedstuffs (Jalili et al. 2013). On the 655 
contrary, higher lysozyme activity was recorded in SPC50 and SPC65 salmon at all 656 
timepoints while higher levels of total IgM were revealed at both timepoints post vaccination 657 
compared to SPC35 salmon. In accordance to the present results, Rumsey et al. (1994) 658 
reported increased lysozyme activity in rainbow trout fed SBM diets. Increased circulatory 659 
total IgM levels, are expected after salmon vaccination explaining the higher amounts at 7 660 
and 34 dpv (Melingen and Wergeland  2000). Superior lysozyme activity in SPC50 and 661 
SPC65 salmon suggests stimulation of the cellular part of immunity and could be a 662 
favourable trait against disease outbreaks (Waagbø et al. 1993; Krogdahl et al. 2000). 663 
Moreover, increased circulating total IgM levels at post vaccination for the aforementioned 664 
groups could improve the effectiveness of vaccination conferring higher protection against 665 
diseases (Krogdahl et al. 2000). 666 
Plasma haemolytic activity as a consequence of the activation of complement factors 667 
(from both alternative and classical pathways) and/or other substances such as lectins and 668 
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haemolysins (Alexander and Ingram, 1992) was not affected linearly by increasing dietary 669 
SPC levels. Prior to and 7 dpv, salmon from different dietary groups exhibited no differences 670 
in plasma haemolytic activity. Sitja-Bobadilla et al. (2005) and Jalili et al. (2013) reported 671 
decreased alternative complement activity in gilthead sea bream (Sparus aurata) and 672 
rainbow trout respectively, fed diets with 70 % protein from plant derived products. The 673 
former study however, exhibited an enhancement of alternative complement activity in 674 
gilthead sea bream fed 50 % of protein from vegetal ingredients. At 34 dpv, there was a 675 
marked increase of haemolytic activity in fish from all the dietary treatments with SPC50, 676 
SPC65 and SPC80 salmon exhibiting higher activity than SPC35 salmon suggesting higher 677 
immunostimulation of these groups at 34 dpv while highlighting dietary modifications that 678 
were not evident prior to vaccination (Thompson et al. 1996; Nikoskelainen et al. 2002). 679 
4. Conclusions 680 
In conclusion, increasing substitution of high quality FM with SPC at a percentage beyond 681 
35% of dietary protein reduced the growth performance and body cross-sectional elemental 682 
concentrations and enhanced several humoral immune responses of juvenile Atlantic 683 
salmon. Diets with 50% of protein from SPC, appropriate supply of lysine, methionine and 684 
threonine and 30 g × kg-1 of P promoted similar growth and elemental composition to a 685 
control diet with 35 % of protein from SPC, mimicking commercial salmon formulations.  686 
Body cross-sectional elemental reductions due to the increasing dietary SPC levels, observed 687 
during the initial 63-day period, were improved at Day 97 (34 dpv). This seems to be both 688 
an effect of the long term provision of juvenile salmon with increasing dietary SPC levels or 689 
an interaction of these diets with vaccination. Moreover, it was shown that exposure of 690 
Atlantic salmon to continuous light, intensive feeding regimes and vaccination may result in 691 
elemental deficiencies rendering developing salmon susceptible to skeletal deformities or 692 
diseases. Under these conditions slow growing salmon fed on high SPC inclusion feeds can 693 
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match their elemental requirements for both growth and bone mineralisation more efficiently 694 
than the faster growing SPC35 fish. Lastly the use of body cross-sections appears to be 695 
promising for the assessment of salmon elemental status, however validation studies are 696 
required to demonstrate the correlation between whole body and body cross-sectional 697 
compositions, from fish reared under the same conditions. While P involvement on growth 698 
and mineral retention in fish is well documented, the implication of P in fish immunity is not 699 
clear (Lall 2003). However, P could affect immunity either directly by supplying the energy 700 
required for immunological stimulation, or indirectly by influencing the digestion of other 701 
dietary elements including Zn, Mg or Ca,  modulating important immune responses (Lall 702 
2003; Kiron 2012). It is proposed that higher supplementation of P (> 30 g×kg-1) and several 703 
other nutrients (e.g. minerals and vitamins) in diets with 65 % or over of protein from SPC 704 
could improve salmon growth, elemental retention and prevent potential compromises in 705 
immune responses. Further studies are required to assess the effect of high SPC inclusion 706 
diets on these aspects and whether the observed increments in immunological responses are 707 
translated into increased disease resistance. 708 
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Figure captions 947 
Figure 1. Observed weight development of the four dietary groups of Atlantic salmon juveniles. 948 
Mean salmon weight (g) per dietary treatment with standard deviations at each timepoint of the study.  949 
Figure 2. Modelled representation of growth performance for the four dietary groups at each 950 
timepoint. (A) Expected mean salmon weight (g) and (B) Expected mean daily weight gain per fish 951 
(g × day-1); (with 95% C.I.) in relation to % SPC inclusion over the course of the study. Black line 952 
connects the expected mean weights of the four dietary groups at Day 36 in the first case and the 953 
expected mean daily weight gains over the period between Day 0 - Day 36 of the feeding trial (prior 954 
to vaccination); Red line connects the expected mean weights at Day 63 and the expected mean daily 955 
weight gains over the period between Day 36 - Day 63 of the feeding trial (prior to vaccination); 956 
Blue line connects the expected mean weights at Day 97 of the feeding trial (34 days post 957 
vaccination) and the expected mean daily weight gains over the period between Day 63 - Day 97 of 958 
the feeding trial (post vaccination period). Shaded regions of the same colours indicate the 95% 959 
confidence interval regions for these values (derived by posterior simulation of the model with 960 
n=1500 random draws). Dashed horizontal lines denote the mean values for the salmon fed diets 961 
with 35% of dietary protein from SPC. Mean values which lie outside the 95% C.I. of the the group 962 
receiving 35% of dietary protein from SPC are considered significant. Asterisks denote significant 963 
differences between salmon fed 35% of protein from SPC and salmon fed diets with higher 964 
percentage of dietary protein from SPC at different timepoints. 965 
Figure 4. Modelled ash, Ca: P ratio, P and Ca pooled body cross-section levels. Statistical models 966 
showing a significant linear effect of the percentage of protein from SPC on pooled body cross-967 
section ash and elemental levels with P values < 0.05; Expected (A) Ash (g × kg-1); (B) Ca: P ratio; 968 
(C) Phosphorus (P) (mg × kg-1); (D) Calcium (Ca) (mg × kg-1) (with 95% C.I.) (y axis) in relation to 969 
% SPC inclusion (x axis) over the course of the study. Red, and blue lines connect the expected mean 970 
values for each measurement at Day 63 post feeding prior to vaccination and Day 97 post feeding 971 
(34 days post vaccination) respectively, while shaded regions of the same colours indicate the 95% 972 
confidence regions for these values (derived by posterior simulation of the model with n=1500 973 
random draws). Dashed horizontal lines of the aforementioned colours denote the mean values for 974 
salmon fed diets with 35% of dietary protein from SPC. Mean values which lie outside the 95% C.I. 975 
of the group receiving 35% of dietary protein from SPC are considered significant. Asterisks of the 976 
same colours denote significant differences between salmon fed 35% of protein from SPC and 977 
salmon fed diets with higher percentage of dietary protein from SPC at different timepoints. 978 
Figure 5. Modelled Mg, Zn and Mn pooled body cross-section levels. Statistical models showing 979 
a significant quadratic or linear effect of the percentage of protein from SPC on pooled body cross-980 
section elemental levels with P values < 0.05; Expected (A) Magnesium (Mg) (mg × kg-1); (B) Zinc 981 
(Zn) (mg × kg-1); (C) Manganese (Mn) (mg × kg-1) (with 95% C.I.) (y axis) in relation to % SPC 982 
inclusion (x axis) over the course of the study. Red, and blue lines connect the expected mean values 983 
for each measurement at Day 63 post feeding prior to vaccination and Day 97 post feeding (34 days 984 
post vaccination) respectively, while shaded regions of the same colours indicate the 95% confidence 985 
regions for these values (derived by posterior simulation of the model with n=1500 random draws). 986 
Dashed horizontal lines of the aforementioned colours denote the mean values for salmon fed diets 987 
with 35% of dietary protein from SPC. Mean values which lie outside the 95% C.I. of the group 988 
receiving 35% of dietary protein from SPC are considered significant. Asterisks of the same colours 989 
denote significant differences between salmon fed 35% of protein from SPC and salmon fed diets 990 
with higher percentage of dietary protein from SPC at different timepoints. 991 
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Figure 5. Modelled haematological responses. Statistical models showing the linear (Models 992 
selected with P values < 0.05) effect of the percentage of dietary protein from SPC on: (A) Expected 993 
haematocrit (%); (B) Expected leucocytes (× 107 × ml-1); (C) Expected lymphocytes (× 107 × ml-1); 994 
(D) Expected thrombocytes (× 107 × ml-1). Red, green and blue lines connect the expected mean 995 
values for each measurement prior to vaccination –pre vacc (Day 63 post feeding), 7 days post 996 
vaccination (7 dpv-Day 70 post feeding) and 34 dpv (Day 97 post feeding) respectively, while shaded 997 
regions of the same colours indicate the 95% confidence regions for these values (derived by 998 
posterior simulation of the model with n=1500 random draws). Dashed horizontal lines of the 999 
aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 1000 
from SPC. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein 1001 
from SPC are considered significant. Asterisks of the same colours denote significant differences 1002 
between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of dietary 1003 
protein from SPC at different timepoints. 1004 
Figure 6. Modelled immunological responses. Statistical models showing significant quadratic 1005 
effect (Models selected with P values < 0.05) of the percentage of protein from SPC on: (A) Expected 1006 
lysozyme activity (Units × min-1 × ml-1); (B) Expected total plasma IgM (mg × ml-1); (C) Expected 1007 
haemolytic activity (Units H50 × ml-1). Red, green and blue lines connect the expected mean values 1008 
for each measurement prior to vaccination –prevacc-(Day 63 post feeding), 7 days post vaccination 1009 
(7 dpv-Day 70 post feeding) and 34 dpv (Day 97 post feeding) respectively, while shaded regions of 1010 
the same colours indicate the 95% confidence regions for these values (derived by posterior 1011 
simulation of the model with n=1500 random draws). Dashed horizontal lines of the 1012 
aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 1013 
from SPC. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein 1014 
from SPC are considered significant. Asterisks of the same colours denote significant differences 1015 
between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of dietary 1016 
protein from SPC at different timepoints.1017 
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Table 1. Formulation and calculated chemical composition of experimental diets with varying soy protein concentrate levels 
Feed composition (× kg-1) SPC35 SPC50 SPC65 SPC80 SPC35 SPC50 SPC65 SPC80 
  2mm 3mm 
Fishmeal a (g) 462.86 344.15 230.64 121.98 462.86 344.15 230.64 121.98 
SPCb (g) 274.64 384.25 489.16 590.97 274.64 384.25 489.16 590.97 
Tapiocac (g) 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 
Di-calcium phosphated (g) 30.00 30.00 30.00 30.00 30.00 30.00 30.00 30.00 
Vitamin and mineral premixese (g) 3.55 3.55 3.55 3.55 3.55 3.55 3.55 3.55 
Vitamin C 35% e (g) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
MgSO4 d (g) 0.45 0.45 0.45 0.45 0.45 0.45 0.45 0.45 
Methionine f (g) 2.10 3.50 4.50 5.50 2.10 3.50 4.50 5.50 
Lysine 78% f (g) 1.80 2.40 2.80 3.30 1.80 2.40 2.80 3.30 
L-Threonine f (g) 0.60 0.70 0.90 0.98 0.60 0.70 0.90 0.98 
Ultralec g (g) 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 
Fish Oil h (g) 113.00 120.00 127.00 132.26 113.00 120.00 127.00 132.26 
Chemical composition (× kg-1)                 
Dry matter (g) 937.4 938.7 932.5 911.9 920.6 907.7 921.3 931.2 
In dry matter basis 
Crude protein (g) 504.2 502.1 491.7 471 501.2 488.9 491.2 485.4 
Crude fat (g) 175.6 166.2 157.6 144.4 174.3 158.5 151.4 146.1 
Crude protein: Crude fat ratio 2.9 3 3.1 3.3 2.9 3.1 3.2 3.4 
Phytic acid (g) 11.9 13.5 14.6 15.3 11.6 13.1 14.2 15.2 
Phytic Acid Bound P (g) 3.4 3.8 4.1 4.3 3.3 3.7 4.0 4.3 
Ash (g) 108.4 106.3 103 97.1 106.2 102.8 100.9 100.1 
Phosphorus (P) (g) 16.6 16.0 15.3 14.6 16.4 16.0 15.5 14.7 
Calcium (Ca) (g) 33.4 26.8 22.5 19.0 31.8 27.8 23.1 18.5 
Ca: P ratio 2 1.7 1.5 1.3 1.9 1.7 1.5 1.3 
Zn (mg) 295.4 285.3 273.4 265.9 287.00 285.5 275.4 268.4 
39 
 
Mg (g) 2.18 2.32 2.39 2.44 2.21 2.34 2.39 2.43 
Mn (mg) 83.54 87.32 86.99 86.78 83.87 87.45 86.32 85.89 
Abbreviations: SPC 35 - diet with 35 % of dietary protein soy protein concentrate (SPC); SPC 50 - diet with 50 % of dietary protein from SPC; 
SPC 65 - diet with 65 % of dietary protein from SPC; SPC 80 - diet with 80% of dietary protein from SPC.  
a Fishmeal (Egersund  Sildoljefabrikk, Norway) with an apparent protein digestibility coefficient (ADC protein) of 90.2 % ; b SPC (~62% crude 
protein) (Imcopa, Paraná, Brazil) with an apparent protein digestibility coefficient (ADC protein) of 90.8 % (Antitrypsins < 3.0 mg × g-1, Fibre < 
5.0 mg × g-1,  Lectins < 0.1 μg × g-1, Saponins = 0% ,  Glycinin < 3.0 μg × g-1, β-conglycinin <  1.0 μg × g-1) (Compositional analyses performed 
by an authorized external laboratory hired by Imcopa) ; c Tapioca (Hoff Norske Potetindustrier, Gjøvik, Norway); d Dicalcium Phosphate (Normin 
AS, Hønefoss, Norway); e Vitamin premix and Mineral premix (EWOS AS, Bergen, Norway); f Amino acids (Evonik Degussa International AG, 
Hanau, Germany); g Ultralec: De-oiled lecithin powder (ADM, Decatur, USA); h Fish Oil (Egersund  Sildoljefabrikk, Norway).  
* The concentrations of phytic acid and phytic acid-bound P were estimated using a Megazyme Phytate/Total Phosphorus Assay kit (Megazyme, 
Ireland) following the protocols provided by the company and were then corrected according to the total dietary P values estimated via ICP/MS.
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Table 2. Performance data of juvenile Atlantic salmon dietary groups. 
Growth and survival SPC35 SPC50 SPC65 SPC80 Linear Quadratic 
Initial weight (g) (Day 0) 29.2±0.49 28.8±0.60 28.6±0.89 28.8±0.80 - - 
Intermediate weight (g) (Day 
36) 
72.7±3.92 69.1±2.91 67.7±6.80 65.7±6.38 P<0.05 NS 
Intermediate weight (g) (Day 
63) 
122.8±1.47 118.6±4.23 110.7±11.12 112.8±5.66 P<0.05 NS 
Final weight (g) (Day 97) 174.1±3.56 169.4±5.70 159.8±9.76 162.4±12.03 P<0.05 NS 
Weight gain*(g×fish-1×day-1) 
(Days 0-36) 
1.21±0.10 1.12±0.08 1.08±0.17 1.03±0.16 P<0.05 NS 
Weight gain*(g×fish-1×day-1) 
(Days 36-63) 
2.05±0.16 2.03±0.07 1.76±0.40 1.93±0.09 P<0.05 NS 
Weight gain*(g×fish-1×day-1) 
(Days 63-97) 
1.48±0.09 1.46±0.08 1.43±0.12 1.42±0.21 P<0.05 NS 
Feed Given (g×fish-1) 
(Days 0-36) 
20.55±0.42 20.24±0.42 20.08±0.62 20.22±0.56 - - 
Feed Given (g×fish-1) 
(Days 36-63) 
25.83±0.65 25.06±1.06 23.53±2.42 23.83±1.68 - - 
Feed Given (g×fish-1) 
(Days 63-97) 
76.09±1.26 73.14±2.37 67.90±7.76 70.11±3.46 - - 
Mortalities (%) 0.8 0 0.8 0 NS NS 
Data for performance represent means ±SD for 4 replicate tanks.  
Abbreviations: SPC 35 - diet with 35 % of dietary protein from soy protein concentrate (SPC); 
SPC 50 - diet with 50 % of dietary protein from SPC; SPC 65 - diet with 65 % of dietary protein 
from SPC; SPC 80 - diet with 80% of dietary protein from SPC.  
*Weight gain (Daily Weight gain) (g fish-1 day-1) = Total weight of fish within treatment (g) × 
(Number of fish within treatment)-1*(Number of trial days)-1.
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Table 2. Ash and elemental composition of Atlantic salmon parr pooled body cross-sections 
Mineral Composition (× kg-1) 
Day 63(prior to 
vaccination) 
SPC35 SPC50 SPC65 SPC80 Linear Quadratic 
Ash (g) 2.12±0.06           2.00±0.03 1.90±0.06        1.83±0.08 P<0.05 NS 
Phosphorus (P) (mg) 4887±208    4875±472   4220±102  4336±314 P<0.05 NS 
Calcium (Ca) (mg) 4265±286    4269±511   3602±95  3069±704 P<0.05 NS 
Ca: P ratio 0.87±0.03           0.87±0.03 0.85±0.01        0.70±0.01 P<0.05 NS 
Magnesium (Mg) (mg) 369±11     351±12   320±4  345±22 NS P<0.05 
Manganese (Mn) (mg) 0.96±0.05           1.09±0.21 0.85±0.11        0.82±0.05 P<0.05 NS 
Zinc (Zn) (mg) 22.02±0.67          22.29±2.78     19.41±0.88       20.88±1.64 P<0.05 NS 
Day 97(34 days  post 
vaccination) 
    
  
Ash (g) 1.77±0.02           1.85±0.05 1.74±0.05        1.71±0.09 P<0.05 NS 
Phosphorus (P) (mg)   3480±25     3602±53   3439±114 3261±62 P<0.05 NS 
Calcium (Ca) (mg)   2127±171     2328±190   2002±101 1816±89 P<0.05 NS 
Ca: P ratio 0.61±0.04           0.65±0.05 0.58±0.02        0.56±0.04 P<0.05 NS 
Magnesium  (Mg) (mg) 305±5 315±5   308±12 298±4 NS P<0.05 
Manganese (Mn) (mg) 0.56±0.05           0.70±0.08 0.58±0.06        0.54±0.02 P<0.05 NS 
Zinc (Zn) (mg) 13.29±1.28          14.60±1.11 13.19±0.67       12.06±0.58 P<0.05 NS 
Data for ash and elemental composition are referred as means ± SD of 4 pooled samples (1 pool of 6 body cross-section homogenates per tank).  
Abbreviations: SPC 35 - diet with 35 % of dietary protein from soy protein concentrate (SPC); SPC 50 - diet with 50 % of dietary protein from SPC; SPC 65 - diet with 65 % 
of dietary protein from SPC; SPC 80 - diet with 80% of dietary protein from SPC. 
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Table 3. Haematological and immunological responses of Atlantic salmon juveniles 
PRE VACCINATION SPC35 SPC50 SPC65 SPC80 Linear Quadratic 
Haematocrit (%) 53.0±4.5 51.9±4.7 51.8±4.7 51.3±4.4 P<0.05 NS 
Leucocytes (× 107× ml-1) 6.7±2.3 7.5± 1.7 7.1± 0.9 6.4 ±2.0 P<0.05 NS 
Lymphocytes (×107× ml-1) 4.2±1.6 4.3±1.1 4.1±0.6 3.6±1.4 P<0.05 NS 
Thrombocytes (×107× ml-1) 2.2±0.9 3.0±1.0 2.6±0.7 2.7±1.2 NS P<0.05 
Granulocytes (×107× ml-1) 0.1±0.1 0.1±0.1 0.1±0.1 0.1±0.04 NS NS 
Monocytes (×107× ml-1) 0.02±0.02 0.02±0.02 0.02±0.02 0.02±0.03 NS NS 
Lysozyme act. (units × min-1× ml-1 of plasma) 369.8±80.4 480.2±90.9 442.1±78.2 389.7±118.5 NS P<0.05 
Haemolytic act. (units H50  × ml-1 of plasma) 444.3±87.9 497.4±130.4 528.4±105.2 416.4±64.8 NS P<0.05 
HKMs resp. burst (NBT) (OD for 105 nuclei) 0.2±0.2 0.2±0.1 0.2±0.1 0.3±0.1 NS NS 
Stimulated HKMs resp. burst (OD for 105 nuclei) 0.4±0.3 0.4±0.2 0.4±0.3 0.5±0.2 NS NS 
Total plasma protein (mg × ml-1 of plasma) 48.3±5.2 49.5±3.6 47.7±2.8 47.4±4.9 NS NS 
Antiprotease activity (Units TI75 × ml-1)** 845.6±96.6 908±39.8 855.7±60.2 891.6±67.4 NS NS 
Total plasma IgM (mg × ml-1 of plasma) 1.9±3.0 1.3±2.3 2.3±2.0 0.9±1.1 NS P<0.05 
7 DAYS POST VACCINATION       
Haematocrit (%) 52.2±5.1 49.4±4.3 51.6±6.7 47.8±4.3 P<0.05 NS 
Leucocytes (× 107 × ml-1) 8.4±1.7 8.5±1.9 8.2±3.0 6.4±2.5 P<0.05 NS 
Lymphocytes (×107× ml-1) 4.5±1.3 4.7±1.5 4.8±1.9 3.5±1.5 P<0.05 NS 
Thrombocytes (×107× ml-1) 3.4±1.0 3.3±0.9 3.1±1.3 2.6±1.2 NS P<0.05 
Granulocytes (×107× ml-1) 0.4±0.3 0.4±0.3 0.4±0.3 0.3±0.2 NS NS 
Monocytes (×107× ml-1) 0.02±0.03 0.04±0.04 0.03±0.04 0.02±0.02 NS NS 
Lysozyme act. (units × min-1× ml-1 of plasma) 639.4±216.0 719.4±75.1 662.0±184.1 698.63±97.0 NS P<0.05 
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Haemolytic act. (units H50 × ml-1 of plasma) 446.0±96.1 447.2±108.1 529.0±133.7 507.6±209.1 NS P<0.05 
HKMs resp. burst (NBT) (OD for 105 nuclei) 0.6±0.5 0.8±0.4 0.9±0.3 0.8±0.2 NS NS 
Stimulated HKMs resp. burst (OD for 105 nuclei) 0.9±0.8 1.0±0.6 1.1±0.4 1.1±0.3 NS NS 
Total plasma protein (mg × ml-1 of plasma) 42.1±5.7 39.5±2.6 40.3±3.1 37.3±3.5 NS NS 
Antiprotease activity (Units TI75 × ml-1)** 653.3±98.6 677.9±138.2 647.1±98.0 667.8±97.6 NS NS 
Total plasma IgM (mg × ml-1 of plasma) 3.6±2.3 4.9±3.6 6.5±4.1 3.8±2.9 NS P<0.05 
34 DAYS POST VACCINATION       
Haematocrit (%) 55.3±4.1 54.5±2.8 54.4±3.3 53.0±4.9 P<0.05 NS 
Leucocytes (× 107× ml-1) 8.7±1.5 8.6±1.5 9.4±2.9 9.3±2.9 P<0.05 NS 
Lymphocytes (×107× ml-1) 4.1±0.9 3.9±1.2 4.8±1.7 5.5±2.7 P<0.05 NS 
Thrombocytes (×107× ml-1) 4.2±1.1 4.5±1.2 4.8±2.2 3.8±1.2 NS P<0.05 
Granulocytes (×107× ml-1) 0.4±0.2 0.2±0.1 0.3±0.2 0.2±0.1 NS NS 
Monocytes (×107× ml-1) 0.05±0.05 0.03±0.03 0.05±0.05 0.04±0.05 NS NS 
Lysozyme act. (units × min-1× ml-1 of plasma) 438.4±68.4 373.3±96.3 450.4±62.7 390.0±78.9 NS P<0.05 
Haemolytic act. (units H50 × ml-1 of plasma) 1183.7±126.7 1344.6±242.2 1424.9±208.2 1072.4±126.9 NS P<0.05 
HKMs resp. burst (NBT) (OD for 105 nuclei) 0.2±0.1 0.3±0.2 0.2±0.1 0.3±0.2 NS NS 
Stimulated HKMs resp. burst (OD for 105 nuclei) 0.3±0.1 0.3±0.2 0.2±0.1 0.3±0.2 NS NS 
Total plasma protein (mg × ml-1 of plasma) 46.4±7.7 8.6±1.5 9.4±2.9 9.3±2.9 NS NS 
Antiprotease activity (Units TI75 × ml-1)** 596.6±15.9 604.0±16.8 600.6±30.2 598.9±11.6 NS NS 
Total plasma IgM (mg × ml-1 of plasma) 3.6±3.8 6.4±2.6 5.6±2.8 2.9±2.2 NS P<0.05 
Specific IgM (plasma titers) 0.02±0.01 0.02±0.01 0.02±0.01 0.02±0.01 NS NS 
Values for immune responses are means ±SD of 8 pools of 2 fish per diet ±SD; haematocrit values are means ±SD of 24 fish; leukocyte and differential leucocyte counts are 
means ± SD of 12 fish per diet. Abbreviations: SPC 35 - diet with 35 % soy protein concentrate (SPC); SPC 50 - diet with 50 % SPC; SPC 65 - diet with 65 % SPC; SPC 80 - 
diet with 80% SPC.  
**Units TI75 × min-1 × ml-1 of plasma. 
 
